300705 logo

Hunan Jiudian Pharmaceutical Co., Ltd. Stock Price

SZSE:300705 Community·CN¥7.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

300705 Share Price Performance

CN¥0
-17.20 (-100.00%)
CN¥0
-17.20 (-100.00%)
Price CN¥0

300705 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and fair value.

1 Risk
3 Rewards

Hunan Jiudian Pharmaceutical Co., Ltd. Key Details

CN¥3.1b

Revenue

CN¥806.8m

Cost of Revenue

CN¥2.2b

Gross Profit

CN¥1.8b

Other Expenses

CN¥469.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 25, 2026
0.95
73.57%
15.36%
18.2%
View Full Analysis

About 300705

Founded
2001
Employees
2221
CEO
Yang Yang
WebsiteView website
www.hnjiudian.com

Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. Its products portfolio includes Pantoprazole Sodium Enteric-coated, Ferrous Succinate, Rosuvastatin Calcium, Ebastine, and Rabeprazole Sodium Enteric-coated Tablets; and Acetylcysteine Granules, Potassium Sodium Hydrogen Citrate Granules, Loxoprofen Sodium Gel Patch, and Ketoprofen gel patch. The company also offers drugs for analgesic, cardio-cerebrovascular, anti-infection, digestive and urinary system, and breathing and anti-allergy. In addition, it provides CMO/CDMO services. The company was founded in 2001 and is based in Changsha, China.

Recent 300705 News & Updates

Recent updates

No updates